Mergers and Acquisitions (M&A): Rallybio (NASDAQ: RLYB) and Candid Therapeutics Announce Merger
New Haven, CT – Rallybio Corporation has announced the acquisition of Candid Therapeutics (https://www.candidrx.com/). According to the company announcement, Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming…